HIV and COPD: impact of risk behaviors and diseases on quality of life
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Smoking worsens quality of life among HIV-infected individuals, but it remains unclear if this association is related simply to smoking or to chronic obstructive pulmonary disease (COPD), the end-organ disease caused by smoking.
Using cross-sectional data from the AIDS Linked to the Intravenous Experience study, we determined the independent effects of smoking, HIV and COPD assessed using the Medical Outcome Studies-HIV questionnaire.
Of 973 participants, 287 (29.5%) were HIV infected and 151 (15.5%) had spirometry-defined obstruction. Eight hundred and thirty-four (85.7%) were current smokers with 23.3 mean pack-years history. HIV infection was independently associated with reduced physical and mental health. COPD was associated with a trend toward worse physical health (−1.48 units; 95%CI −3.33 to 0.38; p = 0.12) and was independently associated with worse mental health (−2.43 units; 95%CI −4.22 to −0.64; p < 0.01). After accounting for COPD and other covariates, smoking was not associated with changes in physical or mental health.
The presence of COPD, rather than smoking, is associated with worse quality of life independent of HIV infection. Diagnosis and management of COPD in former or current smokers with or at risk for HIV may further improve quality of life.
- Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., et al. (2006). The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases, 194, 11–19. CrossRef
- Burgoyne, R. W., & Tan, D. H. (2008). Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act. Journal of Antimicrobial Chemotherapy, 61, 469–473. CrossRef
- Liu, C., Ostrow, D., Detels, R., Hu, Z., Johnson, L., Kingsley, L., et al. (2006). Impacts of HIV infection and HAART use on quality of life. Quality of Life Research, 15, 941–949. CrossRef
- Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV cost and services utilization study. American Journal of Medicine, 108, 714–722. CrossRef
- Lucas, G. M., Mehta, S. H., Atta, M. G., Kirk, G. D., Galai, N., Vlahov, D., et al. (1988). End-stage renal disease, chronic kidney disease in a cohort of African-American HIV-infected, at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS, 2007(21), 2435–2443.
- Kirk, G. D., Merlo, C., O’ Driscoll, P., Mehta, S. H., Galai, N., & Vlahov, D. (2007). HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases, 45, 103–110. CrossRef
- Simone, M. J., & Appelbaum, J. (2008). HIV in older adults. Geriatrics, 63, 6–12.
- Adeyemi, O., Rezai, K., Bahk, M., Badri, S., & Thomas-Gossain, N. (2008). Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort. AIDS Patient Care STDS, 22, 941–945. CrossRef
- Jemal, A., Ward, E., Hao, Y., & Thun, M. (2005). Trends in the leading causes of death in the United States, 1970–2002. JAMA, 294, 1255–1259. CrossRef
- Gomez, F. P., & Rodriguez-Roisin, R. (2002). Global initiative for chronic obstructive lung disease (GOLD) guidelines for chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine, 8, 81–86. CrossRef
- Jones, P. W. (2007). Activity limitation and quality of life in COPD. COPD, 4, 273–278. CrossRef
- Reardon, J. Z., Lareau, S. C., & ZuWallack, R. (2006). Functional status and quality of life in chronic obstructive pulmonary disease. American Journal of Medicine, 119, 32–37. CrossRef
- Carone, M., Bertolotti, G., Anchisi, F., Zotti, A. M., Donner, C. F., & Jones, P. W. (1999). Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of life in chronic respiratory failure group. European Respiratory Journal, 13, 1293–1300. CrossRef
- Burns, D. N., Hillman, D., Neaton, J. D., Sherer, R., Mitchell, T., Capps, L., et al. (1996). Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry beirn community programs for clinical research on AIDS. Journal of Acquired Immune Deficiency Syndromes Human Retrovirology, 13, 374–383.
- Crothers, K., Butt, A. A., Gibert, C. L., Rodriguez-Barradas, M. C., Crystal, S., & Justice, A. C. (2006). Increased COPD among HIV-positive compared to HIV-negative veterans. Chest, 130, 1326–1333. CrossRef
- Diaz, P. T., Clanton, T. L., & Pacht, E. R. (1992). Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Annals of Internal Medicine, 116, 124–128.
- Diaz, P. T., King, M. A., Pacht, E. R., Wewers, M. D., Gadek, J. E., Nagaraja, H. N., et al. (2000). Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals of Internal Medicine, 132, 369–372.
- Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S., et al. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine, 20, 1142–1145. CrossRef
- Reynolds, N. R., Neidig, J. L., & Wewers, M. E. (2004). Illness representation and smoking behavior: A focus group study of HIV-positive men. The Journal of the Association of Nurses in AIDS Care, 15, 37–47. CrossRef
- Vidrine, D. J., Arduino, R. C., & Gritz, E. R. (2007). The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS, 21, 659–666. CrossRef
- Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., et al. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Research Monograph, 109, 75–100.
- Marshall, M. M., McCormack, M. C., & Kirk, G. D. (2009). Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Education and Prevention, 21, 28–39. CrossRef
- Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research, 6, 481–493. CrossRef
- Revicki, D. A., Sorensen, S., & Wu, A. W. (1998). Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey. Medical Care, 36, 126–137. CrossRef
- Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6, 531–554. CrossRef
- Jacobson, D. L., Wu, A. W., & Feinberg, J. (2003). Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. Journal of Clinical Epidemiology, 56, 874–879. CrossRef
- Burgess, A., Dayer, M., Catalan, J., Hawkins, D., & Gazzard, B. (1993). The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis. AIDS, 7, 1001–1008. CrossRef
- Revicki, D. A., Wu, A. W., & Murray, M. I. (1995). Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care, 33, AS173–AS182.
- Copfer, A. E., Ampel, N. M., Hughes, T. E., Gregor, K. J., Dols, C. L., Coons, S. J., et al. (1996). The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison. Quality of Life Research, 5, 281–286. CrossRef
- Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr., Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Medical Care, 29, 786–798. CrossRef
- Schag, C. A., Ganz, P. A., Kahn, B., & Petersen, L. (1992). Assessing the needs and quality of life of patients with HIV infection: development of the HIV overview of problems-evaluation system (HOPES). Quality of Life Research, 1, 397–413. CrossRef
- Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. (2005). Standardisation of spirometry. European Respiratory Journal, 26, 319–338. CrossRef
- Hankinson, J. L., Odencrantz, J. R., & Fedan, K. B. (1999). Spirometric reference values from a sample of the general U.S. population. American Journal of Respiratory Critical Care Medicine, 159, 179–187.
- Ruiz Perez, I., Rodriguez Bano, J., Lopez Ruz, M. A., del Arco Jimenez, A., Causse Prados, M., Pasquau Liano, J., et al. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14, 1301–1310. CrossRef
- Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., et al. (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS, 15, 615–624. CrossRef
- Vidrine, D. J. (2009). Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Education and Prevention, 21, 3–13. CrossRef
- Badia, X., Podzamczer, D., Casado, A., Lopez-Lavid, C., & Garcia, M. (2000). Evaluating changes in health status in HIV-infected patients: Medical outcomes study-HIV and multidimensional quality of life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV validation group. AIDS, 14, 1439–1447. CrossRef
- Delate, T., & Coons, S. J. (2001). The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 32, E47–E52. CrossRef
- Wu, A. W., Jacobson, D., Grant, D., Scott-Lennox, J. (1997). Quality of life scores predict clinical trial attrition and mortality. Abstracts of 4th Conf on Retroviruses Opportun Infect, 31, 298.
- Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., et al. (2006). Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women’s interagency HIV study. American Journal of Public Health, 96, 1060–1065. CrossRef
- Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005). Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 171, 972–977. CrossRef
- Shahriar, J., Delate, T., Hays, R. D., Coons, S. J. (2003). Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes, 1, 25.
- Davis, E. A., & Pathak, D. S. (2001). Psychometric evaluation of four HIV disease-specific quality-of-life instruments. Annals of Pharmacotherapy, 35, 546–552. CrossRef
- Oramasionwu, C. U., Brown, C. M., Ryan, L., Lawson, K. A., Hunter, J. M., & Frei, C. R. (2009). HIV/AIDS disparities: the mounting epidemic plaguing US blacks. Journal of the National Medical Association, 101, 1196–1204.
- Kirkpatrick, P., & Dransfield, M. T. (2009). Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Current Opinion in Pulmonary Medicine, 15, 100–104. CrossRef
- Des Jarlais, D. C., & Friedman, S. R. (1987). HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS, 1, 67–76.
- Overland, E. S., Nolan, A. J., & Hopewell, P. C. (1980). Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. American Journal of Medicine, 68, 231–237. CrossRef
- HIV and COPD: impact of risk behaviors and diseases on quality of life
Quality of Life Research
Volume 19, Issue 9 , pp 1295-1302
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Quality of life
- Chronic obstructive pulmonary disease
- Human immunodeficiency virus
- Injection drug use
- Tobacco use
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, School of Medicine, Johns Hopkins University, 5501 Hopkins Bayview Circle, JHAAC 4B.70, Baltimore, MD, 21224, USA
- 2. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA